Stockreport

ELTP Stock Falls Following Q3 Earnings Decline, Revenue Down Y/Y [Yahoo! Finance]

Elite Pharmaceuticals, Inc.  (ELTP) 
NASDAQ:AMEX Investor Relations: ir.elitepharma.com
PDF This compares to the S&P 500 Index's 1.2% gain over the same time frame. Over the past month, the stock gained 7.6% compared with the S&P 500's 2% rise. Find the lates [Read more]